Reduced intestinal‐to‐diffuse conversion and immunosuppressive responses underlie superiority of neoadjuvant immunochemotherapy in gastric adenocarcinoma

Abstract Neoadjuvant immunochemotherapy (NAIC) achieves superior clinical benefits over neoadjuvant chemotherapy (NAC) in multiple types of human cancers, including gastric adenocarcinoma (GAC). However, it is poorly understood how the malignant epithelial cells and tumor immune microenvironment (TI...

詳細記述

書誌詳細

主要な著者:	Lei Wang, Linghong Wan, Xu Chen, Peng Gao, Yongying Hou, Linyu Wu, Wenkang Liu, Shuoran Tian, Mengyi Han, Shiyin Peng, Yuting Tan, Yuwei Pan, Yuanfeng Ren, Jinyang Li, Haihui Wen, Qin Liu, Mengsi Zhang, Tao Wang, Zhong‐Yi Qin, Junyu Xiang, Dongfeng Chen, Xianfeng Li, Shu‐Nan Wang, Chuan Chen, Mengxia Li, Fan Li, Zhenning Wang, Bin Wang
フォーマット:	Artigo
言語:	Inglês
出版事項:	Wiley 2024-11-01
シリーズ:	MedComm
主題:	gastric adenocarcinoma immunochemotherapy Lauren's classification neoadjuvant therapy tumor immune microenvironment
オンライン･アクセス:	https://doi.org/10.1002/mco2.762
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!